Albert Labs International Corp.
CNQ: ABRT.CN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Canadian Securities Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Navchand Jagpal
- Headquarters
- Burnaby, Canada
- IPO year
- 2023
- Market cap
- CA$372.1K
- Website
- https://albertlabs.com
Loading ABRT…
Loading profile data…Frequently asked questions about ABRT
What does Albert Labs International Corp. (ABRT.CN) do?
Albert Labs International Corp. operates as a clinical research and drug development company. The company focuses on treating patients with urgent and unmet needs, including critical mental health indications. It develops psilocybin-assisted therapies to improve mental health conditions, including anxiety, depression, and oncology-related distre...
Where does ABRT.CN trade?
Albert Labs International Corp. (ABRT.CN) trades on the Canadian Securities Exchange.
What sector is ABRT.CN in?
Albert Labs International Corp. (ABRT.CN) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Albert Labs International Corp.?
Navchand Jagpal is the chief executive officer of Albert Labs International Corp. (ABRT.CN).
Where is Albert Labs International Corp. headquartered?
Albert Labs International Corp. is headquartered in Canada.
Does ABRT.CN pay a dividend?
Albert Labs International Corp. (ABRT.CN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ABRT.CN go public?
Albert Labs International Corp. (ABRT.CN) completed its initial public offering in 2023.